114 related articles for article (PubMed ID: 21365870)
1. [Application of HPLC to meropenem determination in plasma samples of patients with infections treated after coronary artery bypass graft surgery].
Bafeltowska J; Pokorska A; Białek K; Wilczyński M
Rocz Panstw Zakl Hig; 2010; 61(3):323-7. PubMed ID: 21365870
[TBL] [Abstract][Full Text] [Related]
2. Population pharmacokinetics and probability of target attainment of meropenem in critically ill patients.
Mattioli F; Fucile C; Del Bono V; Marini V; Parisini A; Molin A; Zuccoli ML; Milano G; Danesi R; Marchese A; Polillo M; Viscoli C; Pelosi P; Martelli A; Di Paolo A
Eur J Clin Pharmacol; 2016 Jul; 72(7):839-48. PubMed ID: 27048201
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and pharmacodynamics of meropenem in critically ill patients.
Kitzes-Cohen R; Farin D; Piva G; De Myttenaere-Bursztein SA
Int J Antimicrob Agents; 2002 Feb; 19(2):105-10. PubMed ID: 11850162
[TBL] [Abstract][Full Text] [Related]
4. Determination of meropenem in plasma and filtrate-dialysate from patients under continuous veno-venous haemodiafiltration by SPE-LC.
Robatel C; Buclin T; Eckert P; Schaller MD; Biollaz J; Decosterd LA
J Pharm Biomed Anal; 2002 Jun; 29(1-2):17-33. PubMed ID: 12062661
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic and Pharmacodynamic Efficacies of Continuous versus Intermittent Administration of Meropenem in Patients with Severe Sepsis and Septic Shock: A Prospective Randomized Pilot Study.
Zhao HY; Gu J; Lyu J; Liu D; Wang YT; Liu F; Zhu FX; An YZ
Chin Med J (Engl); 2017 May; 130(10):1139-1145. PubMed ID: 28485312
[TBL] [Abstract][Full Text] [Related]
6. Assessment of pharmacokinetic changes of meropenem during therapy in septic critically ill patients.
Goncalves-Pereira J; Silva NE; Mateus A; Pinho C; Povoa P
BMC Pharmacol Toxicol; 2014 Apr; 15():21. PubMed ID: 24731745
[TBL] [Abstract][Full Text] [Related]
7. Determination of meropenem levels in human serum by high-performance liquid chromatography with ultraviolet detection.
Roth T; Fiedler S; Mihai S; Parsch H
Biomed Chromatogr; 2017 May; 31(5):. PubMed ID: 27797104
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of meropenem in critically ill patients with severe infections.
Binder L; Schwörer H; Hoppe S; Streit F; Neumann S; Beckmann A; Wachter R; Oellerich M; Walson PD
Ther Drug Monit; 2013 Feb; 35(1):63-70. PubMed ID: 23318279
[TBL] [Abstract][Full Text] [Related]
9. Quantification of meropenem in plasma and cerebrospinal fluid by micellar electrokinetic capillary chromatography and application in bacterial meningitis patients.
Chou YW; Yang YH; Chen JH; Kuo CC; Chen SH
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Sep; 856(1-2):294-301. PubMed ID: 17625990
[TBL] [Abstract][Full Text] [Related]
10. Determination of meropenem in plasma by high-performance liquid chromatography and a microbiological method.
al-Meshal MA; Ramadan MA; Lotfi KM; Shibl AM
J Clin Pharm Ther; 1995 Jun; 20(3):159-63. PubMed ID: 7593377
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and pharmacodynamics of meropenem in febrile neutropenic patients with bacteremia.
Ariano RE; Nyhlén A; Donnelly JP; Sitar DS; Harding GK; Zelenitsky SA
Ann Pharmacother; 2005 Jan; 39(1):32-8. PubMed ID: 15598967
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous determination of five beta-lactam antibiotics (cefepim, ceftazidim, cefuroxim, meropenem and piperacillin) in human plasma by high-performance liquid chromatography with ultraviolet detection.
Denooz R; Charlier C
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Mar; 864(1-2):161-7. PubMed ID: 18295557
[TBL] [Abstract][Full Text] [Related]
13. Population Pharmacokinetics and Target Attainment of Meropenem in Plasma and Tissue of Morbidly Obese Patients after Laparoscopic Intraperitoneal Surgery.
Wittau M; Scheele J; Kurlbaum M; Brockschmidt C; Wolf AM; Hemper E; Henne-Bruns D; Bulitta JB
Antimicrob Agents Chemother; 2015 Oct; 59(10):6241-7. PubMed ID: 26248353
[TBL] [Abstract][Full Text] [Related]
14. Population pharmacokinetics and Monte Carlo dosing simulations of meropenem during the early phase of severe sepsis and septic shock in critically ill patients in intensive care units.
Jaruratanasirikul S; Thengyai S; Wongpoowarak W; Wattanavijitkul T; Tangkitwanitjaroen K; Sukarnjanaset W; Jullangkoon M; Samaeng M
Antimicrob Agents Chemother; 2015; 59(6):2995-3001. PubMed ID: 25753628
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic evaluation of meropenem and imipenem in critically ill patients with sepsis.
Novelli A; Adembri C; Livi P; Fallani S; Mazzei T; De Gaudio AR
Clin Pharmacokinet; 2005; 44(5):539-49. PubMed ID: 15871639
[TBL] [Abstract][Full Text] [Related]
16. Meropenem-RPX7009 Concentrations in Plasma, Epithelial Lining Fluid, and Alveolar Macrophages of Healthy Adult Subjects.
Wenzler E; Gotfried MH; Loutit JS; Durso S; Griffith DC; Dudley MN; Rodvold KA
Antimicrob Agents Chemother; 2015 Dec; 59(12):7232-9. PubMed ID: 26349830
[TBL] [Abstract][Full Text] [Related]
17. An Open, Randomized, Single-Center, Crossover Pharmacokinetic Study of Meropenem after Intraperitoneal and Intravenous Administration in Patients Receiving Automated Peritoneal Dialysis.
Wiesholzer M; Pichler P; Reznicek G; Wimmer M; Kussmann M; Balcke P; Burgmann H; Zeitlinger M; Poeppl W
Antimicrob Agents Chemother; 2016 May; 60(5):2790-7. PubMed ID: 26902765
[TBL] [Abstract][Full Text] [Related]
18. Penetration of meropenem into human pancreatic juice.
Ikawa K; Kondo N; Nakashima A; Yoshizawa K; Morikawa N; Ikeda K; Murakami Y; Ohge H; Sueda T
Scand J Infect Dis; 2013 May; 45(5):404-6. PubMed ID: 23176150
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of high-dose extended-infusion meropenem during pulmonary exacerbation in adult cystic fibrosis patients: a case series.
Delfino E; Fucile C; Del Bono V; Marchese A; Marini V; Coppo E; Casciaro R; Minicucci L; Giacobbe DR; Martelli A; Viscoli C; Mattioli F
New Microbiol; 2018 Jan; 41(1):47-51. PubMed ID: 29313863
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and pharmacodynamics of continuous infusion meropenem in overweight, obese, and morbidly obese patients with stable and unstable kidney function: a step toward dose optimization for the treatment of severe gram-negative bacterial infections.
Pai MP; Cojutti P; Pea F
Clin Pharmacokinet; 2015 Sep; 54(9):933-41. PubMed ID: 25850987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
